Organigram Global (OGI) Net Income towards Common Stockholders (2018 - 2026)
Organigram Global (OGI) reported Net Income towards Common Stockholders of $23.7 million for Q1 2026, down 19.82% year-over-year from $29.6 million in Q1 2025, and down 0.53% quarter-over-quarter from $23.9 million in Q4 2025.
Organigram Global (OGI) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has 7 years of Net Income towards Common Stockholders data on file, last reported at $23.7 million in Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at $23.7 million, down 19.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $77.2 million (up 81.12% YoY), and the FY2025 annual result was $113.2 million, changed N/A from the prior year.
- Net Income towards Common Stockholders slipped to $23.7 million in Q1 2026 per OGI's latest filing, from $23.9 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $29.6 million in Q1 2025 and troughed at $13.0 million in Q4 2024.
- A 3-year average of $22.5 million and a median of $23.8 million in 2025 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2025 and 2026: Net Income towards Common Stockholders soared 83.26% in 2025, then dropped 19.82% in 2026.
- A 3-year view of Net Income towards Common Stockholders shows it stood at $13.0 million in 2024, then soared by 83.26% to $23.9 million in 2025, then declined by 0.53% to $23.7 million in 2026.
- Business Quant data shows OGI's Net Income towards Common Stockholders at $23.7 million in Q1 2026, $23.9 million in Q4 2025, and $29.6 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 366.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 1.99 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Organigram Global | 714.36 Mn | 656.41 Mn | 11.96 Mn | 23.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.72 Mn |
| Dec 31, 2025 | 23.85 Mn |
| Mar 31, 2025 | 29.59 Mn |
| Dec 31, 2024 | 13.01 Mn |
| May 31, 2021 | 4.77 Mn |
| Feb 28, 2021 | -61.74 Mn |
| Nov 30, 2020 | -28.39 Mn |
| Aug 31, 2020 | -173.93 Mn |
| May 31, 2020 | -64.27 Mn |
| Feb 29, 2020 | -6.83 Mn |
| Nov 30, 2019 | 459,000.00 |
| May 31, 2019 | -7.60 Mn |
| Nov 30, 2018 | -38,000.00 |